Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kingdomway is a China-based publicly traded health and nutrition company focused on nutritional ingredients, dietary supplements, and selected pharmaceutical raw materials. The group combines upstream R&D and manufacturing with downstream consumer brands, and markets products including coenzyme Q10, NMN, algal DHA, ARA, vitamin A, and vitamin D3. It describes synthetic biology, microbial fermentation, biocatalysis, and chemical synthesis as core enabling technologies, and operates manufacturing facilities in China as well as a dietary supplement manufacturing facility in the United States. Kingdomway also owns consumer health and nutrition brands such as Doctor's Best, Zipfizz, Viactiv, and LeanBody. Overall, it is better characterized as a commercial nutrition, nutraceutical, and health-products platform than as a therapeutic drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kingdomway Group.